Phyto Chem India Ltd
Phyto Chem India Ltd (PHYTO) last reported results for the quarter ended Jun 2026, with sales of ₹0.03 crore and net profit of ₹-0.9 crore. The stock last traded at ₹17.5, a market capitalisation of ₹7.52 crore. Over the past 52 weeks the stock has ranged between ₹15.1 and ₹35. Figures are as of 6 Oct 2026 and are not real time.
Phyto Chem India Ltd share price and key metrics
- Current price
- ₹17.5
- Market cap
- ₹7.52 cr
- Book value
- ₹10.6
- ROE
- -32.8%
- ROCE
- -1.57%
- Dividend yield
- 0.00%
- 52w high / low
- 35.0/15.1
Metrics as of 6 Oct 2026. Not real time.
Track Phyto Chem India Ltd
Cruxal reads every Phyto Chem India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Phyto Chem India Ltd growth and returns
- 10 Years
- -8%
- 5 Years
- -27%
- 3 Years
- -30%
- TTM
- -31%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -22100%
- 10 Years
- -6%
- 5 Years
- -4%
- 3 Years
- -27%
- 1 Year
- -35%
- 10 Years
- -3%
- 5 Years
- -14%
- 3 Years
- -29%
- Last Year
- -33%
Phyto Chem India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0.03 cr, down 98.0% from ₹1.5 cr a year earlier. Net profit was ₹-0.9 cr, down 87.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4.37 | 3.65 | 1.46 | 1.5 | 4.36 | 2.97 | 0.23 | 0.03 |
| Expenses | 3.81 | 3.48 | 2.51 | 2.02 | 4.8 | 3.22 | 0.89 | 0.56 |
| Operating profit | 0.56 | 0.17 | -1.05 | -0.52 | -0.44 | -0.25 | -0.66 | -0.53 |
| OPM % | 12.81% | 4.66% | -71.92% | -34.67% | -10.09% | -8.42% | -286.96% | -1,766.67% |
| Other income | 0.01 | 1.94 | 0.51 | 0.4 | 0.31 | 0.31 | 0.82 | 0.04 |
| Interest | 0.38 | 0.52 | 0.57 | 0.33 | 0.35 | 0.47 | 0.36 | 0.36 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 0.11 | 1.51 | -1.19 | -0.54 | -0.57 | -0.5 | -0.29 | -0.94 |
| Tax % | 0.00% | -0.66% | -3.36% | -9.26% | -1.75% | -2.00% | -3.45% | -3.19% |
| Net profit | 0.11 | 1.52 | -1.16 | -0.48 | -0.56 | -0.48 | -0.28 | -0.9 |
| EPS (₹) | 0.26 | 3.53 | -2.70 | -1.12 | -1.30 | -1.12 | -0.65 | -2.09 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Phyto Chem India Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.45 | 58.9 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 14.08 | 9.07 | 7.59 |
| Operating profit | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.6 | -3.27 | -1.34 | -1.86 | -1.88 |
| OPM % | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -9.52% | -20.51% | -24.77% |
| Net profit | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -0.99 | -1.8 | -2.22 |
| EPS (₹) | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -2.30 | -4.19 | -5.16 |
TTM is the trailing twelve months to the most recent quarter.
Phyto Chem India Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
| Reserves | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 2.09 | 0.27 |
| Borrowings | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 15.77 | 20.49 |
| Other liabilities | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 5.72 | 2.99 |
| Total liabilities | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 28.05 |
| Fixed assets | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.39 | 2.07 |
| CWIP | 0.00 | 0.09 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.05 | 0.05 |
| Other assets | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 25.44 | 25.93 |
| Total assets | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 28.05 |
As reported by the company. Total assets equal total liabilities by construction.
Phyto Chem India Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1.53 | 0.76 | 1.95 | 1.49 | -0.71 | 3.41 | 1.42 | 3.41 | 1.77 | 0.91 |
| Cash from investing | 0.16 | 0.24 | 0.26 | -0.39 | 1.06 | 0.05 | 0.21 | -0.05 | 1.02 | 1.62 |
| Cash from financing | -1.76 | -1.02 | -2.19 | -1.10 | -0.40 | -3.45 | -1.70 | -3.26 | -2.91 | -2.56 |
| Net cash flow | -0.06 | -0.01 | 0.02 | -0.01 | -0.05 | 0.01 | -0.07 | 0.10 | -0.12 | -0.02 |
| Free cash flow | 1.46 | -0.54 | 1.11 | 1.04 | 0.44 | 3.30 | 1.44 | 3.15 | 1.79 | 0.90 |
| CFO / operating profit | 67% | 55% | 88% | 77% | -33% | 238% | 56% | -104% | -137% | -45% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Phyto Chem India Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% | 3.27% | -1.57% |
| Debtor days | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 | 369.41 | 659.58 |
| Inventory days | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 | 338.21 | 358.93 |
| Days payable | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 | 91.75 | 26.88 |
| Cash conversion cycle | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 | 615.87 | 991.63 |
| Working capital days | 53.62 | 43.75 | 45.14 | 69.58 | 85.08 | 155.35 | 150.45 | 161.34 | 129.88 | 93.77 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Phyto Chem India Ltd shareholding pattern
Promoters held 40.40% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.19%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 40.40% | 40.40% | 40.40% | 40.40% | 40.40% | 40.40% | 40.40% | 40.40% |
| DIIs | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% |
| Government | 4.63% | 4.63% | 4.63% | 4.63% | 4.63% | 0.00% | 0.00% | 0.00% |
| Public | 54.79% | 54.79% | 54.79% | 54.78% | 54.78% | 59.41% | 59.41% | 59.42% |
| No. of shareholders | 7,198 | 7,247 | 7,213 | 7,245 | 7,303 | 7,354 | 7,337 | 7,314 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Phyto Chem India Ltd corporate filings
- Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 and based on the certificate received from M/s. Bigshare Services Pvt. Ltd. (Registrar and Share Transfer ....Company Updatelow impact
- Phyto Chem (India) Limited's AGM results indicate a decisive shareholder approval with all resolutions passing overwhelmingly, including the adoption of financials and key appointments, with total votes cast exceeding 14 lakh. The company’s e-voting and poll results show near-unanimous support, reflecting strong shareholder backing for management decisions. The resolutions, including leasing out manufacturing capacity, received 99.95% and 97.48% approval respectively, confirming strategic directions. This clear shareholder endorsement could positively influence investor sentiment, potentially supporting a re-rating, especially if the leasing deal or other strategic moves are perceived as value-accretive.AGM/EGMhigh impact
Cruxal's analysis: Phyto Chem (India) Limited reported a successful AGM with all resolutions passing with…
Read the full analysis - We wish to inform you that, in accordance with the Code of Conduct of Prevention of Insider Trading devised by the Compny, as per the SEBI (Prohibhition of Insider Trading) Regulations, ....Insider Trading / SASTlow impact
- We wish to inform you that, in accordance with the Code of Conduct of Prevention of Insider Trading devised by the Compny, as per the SEBI (Prohibhition of Insider Trading) Regulations, ....Insider Trading / SASTlow impact
- Shareholders approve leasing out spare manufacturing capacity at Phyto Chem India Ltd during AGM held on September 29, 2026Company Updatelow impact
Cruxal's analysis: The company announced that at its 37th AGM on September 29, 2026, shareholders approved…
Read the full analysis - Phyto Chem (India) Limited reappoints non-executive director Mr. K. Srinivasa Rao at AGM held on 29th September 2026Company Updatelow impact
Cruxal's analysis: Phyto Chem (India) Limited announced the reappointment of Mr. K. Srinivasa Rao as a…
Read the full analysis - Phyto Chem (India) Limited holds its 37th AGM on 29 September 2026; no immediate financial disclosures or strategic announcements reportedAGM/EGMlow impact
Cruxal's analysis: Phyto Chem (India) Limited conducted its 37th Annual General Meeting on 29 September…
Read the full analysis - Phyto Chem (India) Limited reports no material developments following board meetingBoard Meetinglow impact
Cruxal's analysis: Phyto Chem (India) Limited has formally notified the BSE that its board meeting held on…
Read the full analysis - Phyto Chem (India) Limited schedules Board Meeting for September 29, 2026Board Meetinglow impact
Cruxal's analysis: Phyto Chem (India) Limited has issued a routine regulatory intimation regarding a Board…
Read the full analysis - Phyto Chem India Ltd schedules 37th Annual General Meeting for September 29, 2026Company Updatelow impact
Cruxal's analysis: Phyto Chem India Ltd has published notices in Business Standard and Andhra Prabha…
Read the full analysis - Phyto Chem India Ltd schedules 37th Annual General Meeting for September 29, 2026Corp. Actionlow impact
Cruxal's analysis: Phyto Chem India Ltd has announced the closure of its Register of Members and Share…
Read the full analysis - Phyto Chem (India) Limited to lease spare manufacturing capacity, targeting annual rental income of 1.08 croreAGM/EGMhigh impact
Cruxal's analysis: Phyto Chem (India) Limited has announced a strategic move to lease out its spare…
Read the full analysis - Phyto Chem (India) Limited Reports Significant Q1 FY2027 Financial Decline with Net Loss of 90.47 LakhCompany Updatehigh impact
Cruxal's analysis: Phyto Chem (India) Limited has reported a sharp deterioration in financial performance…
Read the full analysis - Phyto Chem (India) Limited reports significant revenue contraction and net loss for Q1 FY2027Resulthigh impact
Cruxal's analysis: Phyto Chem (India) Limited reported a sharp decline in financial performance for the…
Read the full analysis - Phyto Chem (India) Limited to generate INR 9 lakh monthly rental income via leasing of spare manufacturing facilitiesBoard Meetingmedium impact
Cruxal's analysis: Phyto Chem (India) Limited has announced the leasing of its spare manufacturing…
Read the full analysis - Phyto Chem (India) Limited schedules Board Meeting for June 2026 quarterly resultsBoard Meetinglow impact
Cruxal's analysis: Phyto Chem (India) Limited has formally intimated the BSE regarding a Board Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.